[button : interested : interested : CM228]
We interviewed physician and clinical biochemist Renata Lenárta, M.D., PhD. about SERRAPEPTASE, its medical potential and effects on health.
SERRAPEPTASE, also known as serratiopeptidase, is a proteolytic enzyme that is originally derived from the gut of the silkworm, specifically from the bacterium Serratia marcescens. This enzyme has the ability to break down proteins into smaller peptides and amino acids, making it an interesting tool in medicine and nutritional supplements.
SERRAPEPTASE is primarily used for its anti-inflammatory and fibrinolytic properties.It helps reduce inflammation, swelling and pain by breaking down dysfunctional proteins and improving fluid drainage from affected tissues. It is often prescribed in the treatment of chronic inflammatory conditions such as arthritis, sinusitis, carpal tunnel and more. It is also being investigated for its potential in breaking down biofilms and reducing the risk of bacterial infections.
SERRAPEPTASE has several health benefits.
1. Origin from the silkworm: SERRAPEPATASE was originally isolated from the gut of the silkworm, specifically from the bacterium Serratia marcescens. The silkworm uses this enzyme to break down the pupa as it transforms into a butterfly.
2. Serrapeptase is known for its potent anti-inflammatory properties. It helps break down non-functional proteins and promotes faster tissue healing.
3. Fibrinolytic effects: this enzyme can break down fibrin, which is a protein involved in the formation of blood clots. In this way, it can help reduce the risk of thrombosis and promote better blood circulation.
4. Mucus reduction: SERRAPEPTASE can help with chronic respiratory diseases by reducing the viscosity of mucus, making it easier to expectorate and clear the airways.
5. Potential in the treatment of chronic diseases: its effects in the treatment of chronic diseases such as arthritis, chronic sinusitis and carpal tunnel are being investigated. It has the potential to improve the quality of life of patients suffering from these conditions.
6. SERRAPEPTASE is often used to reduce swelling, pain and inflammation after surgical procedures, which can speed up a patient’s recovery.
7. There is interest in the ability of SERRAPEPTASE to break down biofilms, which are protective layers formed by bacteria. This may increase the effectiveness of antibiotics and reduce the risk of chronic infections.
8. SERRAPEPETASE is now marketed for veterinary purposes for legislative reasons, particularly in the treatment of inflammatory conditions in large breeds.
9. Low toxicity: Studies suggest that SERRAPEPATASE has low toxicity, which means that it is relatively safe at the correct dosage. However, as with any supplement, it is important to consult a doctor or veterinarian about its use.
10. Although SERRAPEPTASE is already used in many therapeutic applications, research is ongoing and new potential medical uses for this enzyme are emerging.
Amazing, yes! As I mentioned, SERRAPEPTASE is used in veterinary medicine, particularly in the treatment of inflammatory conditions in dogs and cats. In animals, it helps reduce inflammation, swelling and pain. For example, it can be used in the treatment of arthritis in elderly dogs or in inflammation of the respiratory tract. However, it is important to consult a veterinarian for its use, as the dosage and safety may vary depending on the species and size of the animal.
As with any drug, there are potential risks and side effects with SERRAPEPTASE. Gastrointestinal upset such as nausea, diarrhea or stomach cramps or allergic reactions.
SERRAPEPATASE research is ongoing and new potential applications are emerging. Its role in the treatment of cardiovascular disease, including the prevention of atherosclerosis and the treatment of chronic venous disease, is currently being investigated. Further studies are focusing on its antimicrobial properties and potential to combat resistant bacteria. Although promising, more clinical trials are needed to confirm its efficacy and safety in different areas of medicine.
Thank you for the interview and for the valuable information!
1. Anti-inflammatory properties: “Serrapeptase exerts its anti-inflammatory effects by breaking down abnormal exudates and proteins. This mechanism is beneficial in conditions such as arthritis and sinusitis.”
(Panagariya A, Sharma AK. “Serratiopeptidase: A systematic review of the existing evidence.” *International Journal of Surgery* 2009;7(1):e48-e54.)
2. Fibrinolytic effects: “The enzyme serrapeptase has been shown to exhibit fibrinolytic activity, which can help in the management of blood clots and promote better circulation.”
(Kee WH, Tan SL, Lee V, Salmon YM. “The treatment of breast engorgement with serrapeptase (Danzen): a randomized double-blind controlled trial.” *Singapore Medical Journal* 1989;30(1):48-54.)
3. Mucus reduction: “Serrapeptase reduces the viscosity of mucus, making it easier to expel and thus improving respiratory function in patients with chronic sinusitis and other respiratory conditions.” (Majima Y, Inagaki M, Hirata K, et al. “The effect of an orally administered proteolytic enzyme on the elasticity and viscosity of nasal mucus in chronic sinusitis.” *Acta Oto-Laryngologica* 1988;105(4-5):399-409.)
4. Postoperative swelling and pain can be significantly reduced with the use of serrapeptase, thus accelerating the healing process.
(Esparza EG, Aragón GE, Arreguin V. “Effects of serrapeptase in modulation of postoperative inflammation.” *Journal of Maxillofacial Surgery* 1984;12(3):139-142.)
5. Degradation of biofilms: “Serrapeptase’s ability to degrade biofilms holds promise for enhancing the efficacy of antibiotics and reducing the risk of persistent infections.”
(Mazzone A, Catalani M, Costanzo M, et al. “Evaluation of serrapeptase in the treatment of patients with chronic airway diseases.” *Journal of International Medical Research* 1990;18(5):379-388.)
6. Research continues, “Ongoing research into serrapeptase is uncovering new therapeutic applications, highlighting its potential role in cardiovascular health and chronic inflammatory conditions.” (Tachibana M, Mizukoshi O, Harada Y, Kawamoto K, Hirata M, Yoshida S. “A multi-center, double-blind study of serrapeptase versus placebo in post-antrotomy buccal swelling.” *Pharmacology* 1984;28(Suppl 1):292-298.)
For legislative reasons, it is currently marketed as a veterinary product.
These citations provide an overview of the various aspects and potential applications of SERRAPEPTASE, emphasizing the scientific basis for its use.